Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an announcement.
Recordati has provided an update on its ongoing share buyback program, launched in December 2025 to support current and future equity-based incentive plans for group management. Between 2 and 6 March 2026, the company repurchased 114,393 ordinary shares at a volume-weighted average price of €47.3173 on the Italian regulated market.
Following these latest transactions, Recordati now holds 5,408,236 treasury shares, representing 2.586% of its share capital. The continued execution of the buyback program underscores its commitment to long-term management incentives and capital management, potentially enhancing alignment between management and shareholder interests.
The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on Borsa Italiana, offering therapies for both general and specialist medicine as well as rare diseases. The company operates across the full value chain from clinical development to production, marketing and licensing of APIs and finished products, and is present in about 150 countries across EMEA, the Americas and APAC with more than 4,580 employees.
Average Trading Volume: 335,528
Technical Sentiment Signal: Hold
Current Market Cap: €9.7B
Find detailed analytics on REC stock on TipRanks’ Stock Analysis page.